ARID1A and ovarian clear cell cancer: It has been reported that a patient with CTNNB1 mutation showed lower immune infiltration in HCC, and ARID1A mutation in ovarian clear cell carcinoma also has a role for immune inhibition [28, 29], which is consistent with our result.